Suchergebnisse - "Mescia, Federica"

PubPharm (21)

1

Proinflammatory cytokines driving cardiotoxicity in COVID-19

enthalten in: Cardiovascular research | 2024

von Colzani, M. | Bargehr, J. | Mescia, F. | +8

CommentIn: Cardiovasc Res. 2024 Jan 25;:. - PMID 38270957

2

Congo Red Staining in Digital Pathology : The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis

enthalten in: Laboratory investigation; a journal of technical methods and pathology | 2023

von Cazzaniga, G. | Bolognesi, M. | Stefania, M. | +10

3

Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity

enthalten in: Cell reports | 2023

von Potts, M. | Fletcher-Etherington, A. | Nightingale, K. | +17

4

A patient-centric modeling framework captures recovery from SARS-CoV-2 infection

enthalten in: Nature immunology | 2023

von Ruffieux, H. | Hanson, A. | Lodge, S. | +21

CommentIn: Nat Immunol. 2023 Feb;24(2):207-208. - PMID 36717724

5

Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor

enthalten in: The Journal of infectious diseases | 2023

von Perera, M. | Greenwood, E. | Crozier, T. | +107

6

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

enthalten in: Frontiers in immunology | 2023

von Hurler, L. | Szilágyi, �. | Mescia, F. | +126

7

SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity

enthalten in: Cell reports | 2022

von Meng, B. | Datir, R. | Choi, J. | +105

8

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

enthalten in: Nature | 2022

von Meng, B. | Abdullahi, A. | Ferreira, I. | +154

UpdateOf: Res Sq. 2022 Jan 17;:. - PMID 35075452

9

B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination

enthalten in: Cell reports | 2022

von Kotagiri, P. | Mescia, F. | Rae, W. | +18

10

Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs

enthalten in: Frontiers in immunology | 2022

von Hurler, L. | Toonen, E. | Kajdácsi, E. | +110